SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 76.42 |
| Enterprise Value ($M) | 161.37 |
| Book Value ($M) | 78.88 |
| Book Value / Share | 0.21 |
| Price / Book | 0.97 |
| NCAV ($M) | -74.60 |
| NCAV / Share | -0.20 |
| Price / NCAV | -1.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -0.06 |
| Return on Equity (ROE) | -0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.41 |
| Current Ratio | 1.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 53.51 |
| Assets | 206.99 |
| Liabilities | 128.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 157.96 |
| Operating Income | 3.86 |
| Net Income | -12.16 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 6.79 |
| Cash from Investing | -17.13 |
| Cash from Financing | 2.98 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| MLLCF – Molecular Partners AG | MLPH – Molecular Pharmacology (USA), Ltd. |
| MODVF – Melcor Developments Ltd. | MSTH – Mystic Holdings, Inc. |
| MTEMQ – Molecular Templates, Inc. |
Financial data and stock pages provided by
Fintel.io